Suggestions
Jawahar Malhotra
Executive VP Technology at Medable, Inc. Hiring senior engineering leaders and engineers. Be a part of the digital transformation of clinical research, transform the patient experience, the site experience, Mobile & Web.
Jawahar Malhotra, PhD is a seasoned technology executive with over 25 years of experience in the industry. He currently serves as the Executive VP Technology at Medable, Inc., a position he has held since April 2021.13
Career Highlights
Throughout his career, Dr. Malhotra has demonstrated a passion for transformative technology and has led organizations through various growth phases. His experience includes:
- Leadership Roles: Prior to joining Medable, he held senior positions at HackerRank, OpenGov Inc., Tealeaf Technology, and Yahoo!1
- Entrepreneurship: Founded interKeel Inc. and served as its CEO and CTO1
- Advisory Roles: Currently serves on the Industry Advisory Board of Manara and as a Board Advisor for Auryc Inc.1
Education and Expertise
Dr. Malhotra's academic background includes:
- PhD from Aarhus University
- M.S. and Ph.D. from Stony Brook University
- B.S. from Stony Brook University1
His areas of expertise encompass cloud infrastructure, data analytics, and scaling startup technologies and teams.
Professional Philosophy
Dr. Malhotra describes himself as passionate about technology that positively transforms the world. He enjoys leading businesses, teams, and individuals through multi-dimensional transformations, and is comfortable working with large, geographically distributed teams.1
Recent Achievements
At Medable, Dr. Malhotra has been part of significant company growth:
- In October 2021, Medable secured $304 million in funding at a $2.1 billion valuation2
- He was hired to scale global development and data science for clinical trials, leveraging his extensive experience in technology leadership3
Dr. Malhotra's role at Medable involves leading the technology efforts in the digital transformation of clinical trials, contributing to the company's mission of accelerating effective therapies to patients.